Literature DB >> 15239970

Adenosine A2A receptors interact with GABAergic pathways to modulate respiration in neonatal piglets.

Christopher G Wilson1, Richard J Martin, Marwan Jaber, Jalal Abu-Shaweesh, Anjun Jafri, Musa A Haxhiu, Syed Zaidi.   

Abstract

GABA and adenosine contribute to respiratory inhibition in early postnatal life. In this study the adenosine A2A receptor agonist CGS21680 was used to evaluate adenosine receptor specificity and the interrelation of adenosine and GABA in the inhibition of inspiratory drive. In neonatal piglets (n = 10), CGS21680 was injected into the fourth ventricle resulting in apnea and/or decreased burst area and frequency of phrenic discharge. Phrenic burst area decreased to 58.9 +/- 8.6% (S.E.M.) after CGS21680 injection (control = 91.8 +/- 1.0%). Expiratory time increased 261.0 +/- 59.9% after CGS21680 from control (87.7 +/- 2.7%). When bicuculline was injected locally within the rostral ventrolateral medulla (n = 5), or into the fourth ventricle (n = 5), the CGS21680 induced inhibition of phrenic was abolished. To define expression of A2A receptor at the message level (mRNA), we employed in situ hybridization with a digoxigenin-coupled oligonucleotide. Adenosine A2A receptor mRNA was expressed in regions of the medulla oblongata known to contain GABAergic neurons. We conclude that GABAergic inputs affecting respiratory timing and inspiratory drive are modulated by activation of A2A receptors. These findings offer new insight into the mechanism whereby xanthine therapy diminishes apnea of prematurity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15239970     DOI: 10.1016/j.resp.2004.04.012

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  22 in total

1.  Inhibition of the hypercapnic ventilatory response by adenosine in the retrotrapezoid nucleus in awake rats.

Authors:  Bárbara Falquetto; Luiz M Oliveira; Ana C Takakura; Daniel K Mulkey; Thiago S Moreira
Journal:  Neuropharmacology       Date:  2018-05-23       Impact factor: 5.250

2.  NTS adenosine A2a receptors inhibit the cardiopulmonary chemoreflex control of regional sympathetic outputs via a GABAergic mechanism.

Authors:  Zeljka Minic; Donal S O'Leary; Tadeusz J Scislo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-04-24       Impact factor: 4.733

Review 3.  Adenosine A₂a receptors and O₂ sensing in development.

Authors:  Brian J Koos
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-15       Impact factor: 3.619

Review 4.  The Role of Caffeine in Noninvasive Respiratory Support.

Authors:  Nicole R Dobson; Ravi Mangal Patel
Journal:  Clin Perinatol       Date:  2016-09-28       Impact factor: 3.430

5.  An adenosine A(2A) agonist injected in the nucleus of the solitary tract prolongs the laryngeal chemoreflex by a GABAergic mechanism in decerebrate piglets.

Authors:  Philip M Duy; Luxi Xia; Donald Bartlett; J C Leiter
Journal:  Exp Physiol       Date:  2010-04-23       Impact factor: 2.969

Review 6.  Adenosine kinase: exploitation for therapeutic gain.

Authors:  Detlev Boison
Journal:  Pharmacol Rev       Date:  2013-04-16       Impact factor: 25.468

7.  Effects of Preinjury and Postinjury Exposure to Caffeine in a Rat Model of Traumatic Brain Injury.

Authors:  Theresa A Lusardi; Nikki K Lytle; Hoda M Gebril; Detlev Boison
Journal:  J Caffeine Adenosine Res       Date:  2020-03-04

Review 8.  Caffeine therapy in preterm infants.

Authors:  Hesham Abdel-Hady; Nehad Nasef; Abd Elazeez Shabaan; Islam Nour
Journal:  World J Clin Pediatr       Date:  2015-11-08

9.  An adenosine A(2A) antagonist injected in the NTS reverses thermal prolongation of the LCR in decerebrate piglets.

Authors:  Luxi Xia; Donald Bartlett; J C Leiter
Journal:  Respir Physiol Neurobiol       Date:  2008-08-15       Impact factor: 1.931

10.  Naked mole rats exhibit metabolic but not ventilatory plasticity following chronic sustained hypoxia.

Authors:  Danielle Chung; Yvonne A Dzal; Allison Seow; William K Milsom; Matthew E Pamenter
Journal:  Proc Biol Sci       Date:  2016-03-30       Impact factor: 5.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.